Literature DB >> 10516652

Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation.

M Cavicchi1, B J Whittle.   

Abstract

1. The inducible isoform of nitric oxide synthase (iNOS) may be involved in the pathogenesis of inflammatory bowel disease. Using the human intestinal epithelial cell line, Caco-2, iNOS expression, regulation and sensitivity to the glucocorticoid, dexamethasone after cytokine exposure and its relationship to the degree of differentiation has been studied. 2. NOS activity, assessed by NO2- and NO3- release, was time-dependently increased after exposure to interferon gamma alone or in combination with interleukin-1beta and tumour necrosis factor alpha. 3. Cytokine-induced iNOS activity was increased with days in culture over 20 days and number of passages, suggesting iNOS up-regulation during enterocyte-like differentiation. This activity was inhibited by the selective iNOS inhibitor 1400 W (0.1 - 100 microM). In addition, iNOS protein induction was confirmed by Western blot. 4. Actinomycin D (5 microg ml(-1) inhibited cytokine-induced iNOS activity, protein expression and mRNA level. Pyrrolidine dithiocarbamate (PDTC: 10 - 200 microM) and 3,4 dichloroisocoumarin (0.1 - 100 microM) reduced cytokine-induced iNOS activity and protein expression at both day 10 and 15 after confluence. PDTC also decreased iNOS mRNA levels, suggesting NF-kappaB involvement in its transcription at these times. 5. The tyrphostins A25 and B42 reduced cytokine-induced iNOS activity at both day 10 and 15 after confluence, indicating the JAK-2 kinase is also involved at these times. The tyrphostins also reduced the iNOS protein expression. 6. Dexamethasone (0.1 - 10 microM, for 24 h) reduced cytokine-induced iNOS activity at day 15 and 20 after cell confluence, but not at day 5 or 10. 7. Dexamethasone (5 microM) decreased cytokine-induced iNOS protein expression at day 10 as well as at day 15 after confluence. 8. These findings indicate that iNOS induction and its inhibition by dexamethasone in this human intestinal epithelial cell line is dependent on the degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516652      PMCID: PMC1571669          DOI: 10.1038/sj.bjp.0702827

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

Review 1.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

Review 2.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

3.  Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.

Authors:  P A Sherman; V E Laubach; B R Reep; E R Wood
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

Review 4.  Nuclear receptor/AP-1 interaction.

Authors:  M Pfahl
Journal:  Endocr Rev       Date:  1993-10       Impact factor: 19.871

5.  Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.

Authors:  M W Radomski; D C Jenkins; L Holmes; S Moncada
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

6.  Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  N K Boughton-Smith; S M Evans; C J Hawkey; A T Cole; M Balsitis; B J Whittle; S Moncada
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

7.  Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

Authors:  B L Tepperman; J F Brown; B J Whittle
Journal:  Am J Physiol       Date:  1993-08

8.  Bile salts determine leukotriene B4 synthesis in a human intestinal cell line (CaCo-2).

Authors:  V C Dias; E A Shaffer; J L Wallace; H G Parsons
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

9.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation.

Authors:  D C Jenkins; I G Charles; S A Baylis; R Lelchuk; M W Radomski; S Moncada
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more
  6 in total

1.  Nitric oxide blocks cellular heme insertion into a broad range of heme proteins.

Authors:  Syed Mohsin Waheed; Arnab Ghosh; Ritu Chakravarti; Ashis Biswas; Mohammad Mahfuzul Haque; Koustubh Panda; Dennis J Stuehr
Journal:  Free Radic Biol Med       Date:  2010-03-06       Impact factor: 7.376

2.  Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the rat.

Authors:  Premila Abraham; Indirani K; Desigamani K
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

3.  An essential role of the JAK-STAT pathway in ischemic preconditioning.

Authors:  Y T Xuan; Y Guo; H Han; Y Zhu; R Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins.

Authors:  Dolores Jiménez; M José Martin; David Pozo; Catalina Alarcón; José Esteban; Leo Bruseghini; Antonio Esteras; Virginia Motilva
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction.

Authors:  I-Sarah Lean; Stuart A C McDonald; Mona Bajaj-Elliott; Richard C G Pollok; Michael J G Farthing; Vincent McDonald
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  DNA methylation is required for the control of stem cell differentiation in the small intestine.

Authors:  Karyn L Sheaffer; Rinho Kim; Reina Aoki; Ellen N Elliott; Jonathan Schug; Lukas Burger; Dirk Schübeler; Klaus H Kaestner
Journal:  Genes Dev       Date:  2014-03-15       Impact factor: 11.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.